2024-11-27 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis Report

This report analyzes Intuitive Surgical Inc. (ISRG), a company that develops, manufactures, and markets robotic-assisted surgery systems.

**1. Performance Relative to S&P 500 (VOO):**

ISRG has significantly outperformed the S&P 500 (VOO) over the measured period.  The cumulative return for ISRG is 332.27%, while VOO's is 128.31%. This results in a difference of 204.0%, placing it in the 94.4th percentile of its historical performance relative to the S&P 500 based on the provided data.  The provided alpha consistently above 1 suggests outperformance relative to the market.  The beta is above 1 indicating higher volatility than the market.  Capitalization has significantly increased over the analyzed period.

**2. Recent Price Movement:**

* **Closing Price:** 536.55 (Last Market: 541.04)
* **5-Day Moving Average:** 543.14
* **20-Day Moving Average:** 528.07
* **60-Day Moving Average:** 502.09

The stock price is currently trading slightly below its 5-day moving average, suggesting some recent downward pressure.  However, it's above both its 20-day and 60-day moving averages, indicating a potential upward trend in the medium to long term.  The difference between the last market price and closing price is minimal, suggesting a stable close.

**3. Technical Indicators and Expected Return:**

* **RSI:** 64.83 (Neither overbought nor oversold; relatively neutral)
* **PPO:** 0.01 (Near zero, indicating a relatively flat trend.)
* **20-Day Relative Strength Change:** -2.3% (Minor short-term downward pressure)
* **Expected Return (2+ years):** 122.6% (Significant outperformance of the S&P 500 expected over the long term).  The 541.04 closing price does not suggest any significant sudden price changes (no evidence of a sharp jump or drop).

**4. Recent Financial Performance and Outlook:**

The provided financial data shows consistent revenue growth and strong profit margins.  EPS has remained relatively stable with slight fluctuations.  To provide a more complete analysis, comparative data (year-over-year, quarter-over-quarter growth rates) and an analyst consensus for the most recent earnings would greatly improve the assessment.  The most recent earnings (2024-10-18) show a positive trend, exceeding the previous quarters. However, without a comparison to analyst expectations, a definitive judgment on performance cannot be made.


| Date       | EPS   | Revenue    |
|------------|-------|------------|
| 2024-10-18 | 1.59  | $2.04 B    |
| 2024-07-19 | 1.48  | $2.01 B    |
| 2024-04-19 | 1.54  | $1.89 B    |
| 2023-10-20 | 1.18  | $1.74 B    |
| 2024-10-18 | 1.18  | $1.74 B    | *(Duplicate entry - likely a data error)*


**5. Revenue and Profitability:**  Consistent high profit margins are evident. The data suggests strong financial health with substantial revenue.  A trend analysis of these figures would provide a better understanding of the growth rate.

**6. Capital and Profitability:**

Equity has shown steady growth, and ROE fluctuates but remains positive, indicating healthy profitability.  Analyzing trends in ROE would provide further insights into profitability.


**7. News and Recent Issues:**

(This section requires accessing recent news sources like Shacknews and Finbold within the past two days.  Please provide the dates for a more accurate report).  A review of recent news articles, particularly earnings announcements and analyst reports, is crucial to understanding recent market sentiment and any significant news affecting the stock price.


**8. Overall Summary:**

ISRG has historically outperformed the S&P 500 significantly.  Current technical indicators suggest a neutral-to-positive outlook, with upward momentum evident in the longer-term moving averages.  Financials show strong revenue and profit margins.  However, a more detailed analysis, including analyst expectations for the most recent earnings report, and recent news events, would provide a more comprehensive and accurate assessment of the stock's current valuation and future prospects.  The long-term outlook, based on the provided expected return, remains highly positive.


**9. Disclaimer:** This analysis is based on the limited data provided and should not be considered financial advice.  Conduct thorough research and consult with a financial advisor before making any investment decisions.
